dr. Vladimir Jokić

specijalista opšte hirurgije
Obrazovanje: 
  • Doktor medicine- Medicinski fakultet univerziteta u Beogradu 2015.
  • Specijalista opšte hirurgije-Institut za onkologiju radiologiju Srbije 2022.
  • Doktorske studije na modulu “Biologija tumora i oksidativna oboljenja” – Medicinski fakultet univerziteta u Beogradu 2019.
Radno iskustvo:
  • u periodu od 2017 do 2022 doktor medicine na odseku hirurgije raka dojke i odseku abdominalne hirurgije i sarkoma- Institut za onkologiju i radiologiju Srbije.
  •  2022. specijalista opšte hirurgije-klinika za onkološku hirurgiju-Institut za onkologiju i radiologiju Srbije.
  • Načelnik na odseku za specijalističko-konsultativne preglede, Instituta za onkologiju i radiologiju Srbije 2025.
  • Istraživač pripravnik 2021. Institut za onkologiju i radiologiju Srbije.
  • Učesnik u studiji 2017. – “A controlled, randomized, double blind, phase II study to evaluate efficacy and safety of topical PeproStat in intraoperative surgical haemostasis” sponzorisan od strane Haemostatix Ltd., BioCity Nottingham, NG 1 1GF, UK, 2017. godine.
  • Učesnik konzilijuma na Institutu za onkologiju i radiologiju Srbije: konzilijum za dojku,  konzilijum za štitastu žlezdu, konzilijum za melanom, konzilijum za abdominalnu hirurgiju, konzilijum za kožu i meka tkiva/sarkome.
  • Učesnik “online” konzilijuma u Srbiji.
  • Član Srpskog lekarskog društva-hirurška sekcija.
  • Član udruženja onkoloških hirurga Srbije
  • Učesnik i predavač na kancerološkoj nedelji Beograd-IORS: 2021, 2022, 2023, 2024, 2025.
  • Član udruženja medikalnih onkologa Srbije: učesnik i predavač 2021, 2023, 2025
  •  
Oblast rada:
  • lečenje promena u dojkama, hirurško lečenje tumora dojke;
  • hirurško lečenje bolesti štitaste žlezde;
  • hirurško lečenje promena na koži i mekim tkivima.
Radovi:

PUBLIKACIJE-koautor:

 

  1. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.

Jokic S, Markovic I, Bukumiric Z, Jokic V, Rakovic M, Tripkovic J, Stojiljkovic D, Spurnic I, Jevric M, Matic M, Dobrosavljevic D.J BUON. 2018 Mar-Apr;23(2):468-474.PMID: 29745094 

 

  1. Hyperthermic intrathoracic chemotherapy (HITHOC) in ovarian carcinoma – a propos of a case.

Stojiljkovic D, Nikolic S, Cvetkovic A, Jokic V, Spurnic I, Jokic S, Goran M, Kocic M, Miletic N, Filipovic J, Stojiljkovic T, Lukac B.J BUON. 2018 Dec;23(7):153-155.PMID: 30722125 

 

  1. Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: The EuroPOWER international observational study. Ripollés-Melchor J, Abad-Motos A, Cecconi M, Pearse R, Jaber S, Slim K, Francis N,; EuroPOWER Study Investigators Group; Spanish Perioperative Audit and Research Network (RedGERM-SPARN); Francophone Group for Enhanced Recovery After Surgery (GRACE).J Clin Anesth. 2022 Sep;80:110752. doi: 10.1016/j.jclinane.2022.110752. Epub 2022 Apr 8.PMID: 35405517
  2. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study.

Fotopoulou C, Khan T, Bracinik J, Glasbey J, Abu-Rustum N, Chiva L, Fagotti A, Fujiwara K, Ghebre R, Gutelkin M, Konney TO, Ng J, Pareja R, Kottayasamy Seenivasagam R, Sehouli J, Surappa STS, Bhangu A, Leung E, Sundar S; CovidSurg Gynecological Cancer Collaborators.Am J Obstet Gynecol. 2022 Nov;227(5):735.e1-735.e25. doi: 10.1016/j.ajog.2022.06.052. Epub 2022 Jun 30.PMID: 35779589 

 

  1. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.

COVIDSurg Collaborative.Lancet Oncol. 2021 Nov;22(11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5.PMID: 34624250 

 

  1. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.

COVIDSurg Collaborative; GlobalSurg Collaborative.Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560. Epub 2021 Aug 9.PMID: 34371522 

 

  1. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.

COVIDSurg Collaborative, GlobalSurg Collaborative.Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101.PMID: 33761533 

 

  1. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic.

COVIDSurg Collaborative.Br J Surg. 2021 Jan 27;108(1):88-96. doi: 10.1093/bjs/znaa051.PMID: 33640908 

 

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.

COVIDSurg Collaborative; GlobalSurg Collaborative.Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24.PMID: 34428858 

 

  1. Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.

COVIDSurg Collaborative.Cancer. 2021 Jul 15;127(14):2476-2488. doi: 10.1002/cncr.33320. Epub 2020 Dec 21.PMID: 33345297

 

  1. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.

COVIDSurg Collaborative; GlobalSurg Collaborative.Anaesthesia. 2021 Jun;76(6):748-758. doi: 10.1111/anae.15458. Epub 2021 Mar 9.PMID: 33690889 

 

  1. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.

STARSurg Collaborative and COVIDSurg Collaborative.Br J Surg. 2021 Dec 1;108(12):1448-1464. doi: 10.1093/bjs/znab336.PMID: 34871379 

 

  1. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-Méndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative.J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6.PMID: 33021869 

 

Koautorski rad u izradi 3 knjige:

 

Izolovana perfuzija kao regionalna terapija maligniteta, doc S. Nikolić i saradnici.

 

Tumori peritoneuma, doc S. Nikolić i saradnici.

 

Tumori jetre, doc S. Nikolić i saradnici.

 

 

Poster prezentacije -Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy. PSOGI 2023 S. Nikolic, V. Jokic, L. Pejnovic

 

Jezici komunikacije:
  • Engleski jezik
  • Srpski jezik

Cenovnik usluga

Zakažite online